Mount Vernon Associates Inc Johnson & Johnson Transaction History

Mount Vernon Associates Inc

  • $121 Million
  • Q3 2024

A detailed history of Mount Vernon Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Mount Vernon Associates Inc holds 1,940 shares of JNJ stock, worth $280,271. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,940
Previous 2,095 7.4%
Holding current value
$280,271
Previous $306,000 2.61%
% of portfolio
0.26%
Previous 0.27%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$145.48 - $167.38 $22,549 - $25,943
-155 Reduced 7.4%
1,940 $314,000
Q2 2024

Jul 19, 2024
SELL
$144.38 - $157.78 $40,570 - $44,336
-281 Reduced 11.83%
2,095 $306,000
Q1 2024

Apr 22, 2024
SELL
$155.22 - $162.74 $1,552 - $1,627
-10 Reduced 0.42%
2,376 $375,000
Q4 2023

Jan 26, 2024
SELL
$145.6 - $158.88 $3,494 - $3,813
-24 Reduced 1.0%
2,386 $374,000
Q4 2022

Jan 23, 2023
SELL
$160.2 - $179.79 $4,806 - $5,393
-30 Reduced 1.23%
2,410 $426,000
Q3 2022

Oct 21, 2022
SELL
$161.33 - $179.52 $1,613 - $1,795
-10 Reduced 0.41%
2,440 $399,000
Q2 2022

Jul 22, 2022
SELL
$168.19 - $186.01 $3,363 - $3,720
-20 Reduced 0.81%
2,450 $435,000
Q1 2022

Apr 25, 2022
SELL
$158.14 - $179.59 $5,534 - $6,285
-35 Reduced 1.4%
2,470 $438,000
Q3 2021

Oct 20, 2021
SELL
$161.5 - $179.47 $4,037 - $4,486
-25 Reduced 0.99%
2,505 $405,000
Q1 2021

Apr 21, 2021
SELL
$153.07 - $170.48 $5,357 - $5,966
-35 Reduced 1.36%
2,530 $416,000
Q4 2020

Jan 25, 2021
SELL
$137.11 - $157.38 $2,056 - $2,360
-15 Reduced 0.58%
2,565 $404,000
Q3 2020

Oct 23, 2020
SELL
$140.38 - $153.83 $4,913 - $5,384
-35 Reduced 1.34%
2,580 $384,000
Q2 2020

Jul 27, 2020
SELL
$128.81 - $155.51 $644 - $777
-5 Reduced 0.19%
2,615 $368,000
Q1 2020

Apr 23, 2020
SELL
$111.14 - $153.99 $1,111 - $1,539
-10 Reduced 0.38%
2,620 $344,000
Q3 2019

Oct 16, 2019
SELL
$126.95 - $142.14 $12,695 - $14,213
-100 Reduced 3.66%
2,630 $340,000
Q2 2019

Jul 30, 2019
SELL
$131.15 - $144.24 $228,332 - $251,121
-1,741 Reduced 38.94%
2,730 $380,000
Q2 2019

Jul 25, 2019
BUY
$131.15 - $144.24 $228,332 - $251,121
1,741 Added 63.77%
4,471 $623,000
Q4 2018

Jan 24, 2019
SELL
$122.84 - $147.84 $12,284 - $14,784
-100 Reduced 3.53%
2,730 $352,000
Q2 2018

Jul 27, 2018
BUY
$119.4 - $131.76 $17,910 - $19,764
150 Added 5.6%
2,830 $343,000
Q1 2018

Apr 19, 2018
SELL
$125.1 - $148.14 $12,510 - $14,813
-100 Reduced 3.6%
2,680 $343,000
Q4 2017

Jan 24, 2018
SELL
$131.22 - $143.62 $6,561 - $7,181
-50 Reduced 1.77%
2,780 $388,000
Q3 2017

Oct 24, 2017
BUY
$129.47 - $135.38 $366,400 - $383,125
2,830
2,830 $368,000

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mount Vernon Associates Inc Portfolio

Follow Mount Vernon Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Vernon Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mount Vernon Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email